Hermann Friedrich Wimmer - 05 Aug 2022 Form 3 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
19 Aug 2022, 08:49:59 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jonathan Leiken, Attorney-in-fact for Hermann Friedrich Wimmer
Filing notes and source

Key filing fact

Hermann Friedrich Wimmer filed Form 3 for DIEBOLD NIXDORF, Inc (DBD) on 19 Aug 2022.

Key facts

  • This page summarizes Hermann Friedrich Wimmer's Form 3 filing for DIEBOLD NIXDORF, Inc (DBD).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2022, 08:49.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DBD holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
145,750
Date
05 Aug 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DBD holding Derivative

Non-Qualified Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
05 Aug 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
46,516
Exercise price
$4.08
Footnotes
F2
DBD holding Derivative

Non-Qualified Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
05 Aug 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
12,377
Exercise price
$11.96
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Number includes restricted stock units.

Footnote F2

Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .